BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 2457827)

  • 1. [Relationship between clinical and endocrinological features following transsphenoidal surgery of acromegaly. With special reference to somatomedin-C level].
    Osawa M; Kobayashi S; Takemae T; Nakagawa F
    Neurol Med Chir (Tokyo); 1988 Mar; 28(3):254-8. PubMed ID: 2457827
    [No Abstract]   [Full Text] [Related]  

  • 2. Value of growth hormone dynamics and somatomedin C (insulin-like growth factor I) levels in predicting the long-term benefit after transsphenoidal surgery for acromegaly.
    Arafah BM; Rosenzweig JL; Fenstermaker R; Salazar R; McBride CE; Selman W
    J Lab Clin Med; 1987 Mar; 109(3):346-54. PubMed ID: 3102658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatomedin-C in active and successfully treated acromegaly.
    Knappe G; Hesse V; Jahreis G; Rohde W; Gerl H
    Exp Clin Endocrinol; 1988 Mar; 91(1):2-6. PubMed ID: 3371416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between somatomedin-C and growth hormone levels in acromegaly: basal and dynamic evaluation.
    Oppizzi G; Petroncini MM; Dallabonzana D; Cozzi R; Verde G; Chiodini PG; Liuzzi A
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1348-53. PubMed ID: 2878007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of selective transsphenoidal adenomectomy by endocrinological testing and somatomedin-C measurement in acromegaly.
    Losa M; Oeckler R; Schopohl J; Müller OA; Alba-Lopez J; von Werder K
    J Neurosurg; 1989 Apr; 70(4):561-7. PubMed ID: 2647918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical study of the growth hormone response to dynamic tests and the insulin growth factor assay in acromegaly after microsurgery.
    Schaison G; Couzinet B; Moatti N; Pertuiset B
    Clin Endocrinol (Oxf); 1983 Jun; 18(6):541-9. PubMed ID: 6411389
    [No Abstract]   [Full Text] [Related]  

  • 7. Investigation of the criteria for assessing the outcome of treatment in acromegaly.
    Lindholm J; Giwercman B; Giwercman A; Astrup J; Bjerre P; Skakkebaek NE
    Clin Endocrinol (Oxf); 1987 Nov; 27(5):553-62. PubMed ID: 3450453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acromegaly with 'normal' serum growth hormone levels. Clinical features, diagnosis and results of transsphenoidal microsurgery.
    Brockmeier SJ; Buchfelder M; Adams EF; Schott W; Fahlbusch R
    Horm Metab Res; 1992 Aug; 24(8):392-400. PubMed ID: 1526628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Criteria for the cure of acromegaly: comparison between basal growth hormone and somatomedin C plasma concentrations in active and non-active acromegalic patients.
    Giannella-Neto D; Wajchenberg BL; Mendonça BB; Almeida SF; Macchione M; Spencer EM
    J Endocrinol Invest; 1988 Jan; 11(1):57-60. PubMed ID: 3361077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent results of secondary transnasal surgery for residual or recurring acromegaly.
    Abe T; Lüdecke DK
    Neurosurgery; 1998 May; 42(5):1013-21; discussion 1021-2. PubMed ID: 9588545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The importance of insulin-like growth factor (somatomedin) measurements in the diagnosis and surveillance of acromegaly.
    Rieu M; Girard F; Bricaire H; Binoux M
    J Clin Endocrinol Metab; 1982 Jul; 55(1):147-53. PubMed ID: 7042736
    [No Abstract]   [Full Text] [Related]  

  • 12. Transsphenoidal microhypophysectomy in acromegaly.
    U HS; Wilson CB; Tyrrell JB
    J Neurosurg; 1977 Dec; 47(6):840-52. PubMed ID: 925741
    [No Abstract]   [Full Text] [Related]  

  • 13. Transsphenoidal hypophysectomy for pituitary tumours.
    Dalton G
    Proc R Soc Med; 1974 Sep; 67(9):885-9. PubMed ID: 4431803
    [No Abstract]   [Full Text] [Related]  

  • 14. Discrepancies between bioassayable somatomedin activity and somatomedin C levels in acromegalic patients.
    Jasper HG; Artese R; Molocznik I; Bruno O
    Medicina (B Aires); 1986; 46(4):440-4. PubMed ID: 3574106
    [No Abstract]   [Full Text] [Related]  

  • 15. Lipid metabolism in acromegalic patients before and after selective pituitary adenomectomy.
    Tsuchiya H; Onishi T; Mogami H; Iida M
    Endocrinol Jpn; 1990 Dec; 37(6):797-807. PubMed ID: 2129301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Value and results of trans-sphenoid surgery of the hypophysis in acromegaly].
    Knappe G
    Z Arztl Fortbild (Jena); 1992 Oct; 86(20):1013-7. PubMed ID: 1441638
    [No Abstract]   [Full Text] [Related]  

  • 17. Plasma growth hormone profile in acromegaly before and ten days after transsphenoidal surgery.
    Edén S; Bengtsson BA; Albertsson-Wikland K; Elfversson J; Lindstedt G; Lundberg PA; Petruson B; Rosberg S
    Acta Endocrinol (Copenh); 1989 Jan; 120(1):113-20. PubMed ID: 2492135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neurosurgical treatment of acromegaly].
    Astrup J; Kjaersgaard JO; Damsgaard EM
    Ugeskr Laeger; 1993 Jul; 155(27):2142-7. PubMed ID: 8328067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acromegaly with normal growth-hormone levels and pituitary histology. Case report.
    Feingold KR; Goldfine ID; Weinstein PR
    J Neurosurg; 1979 Apr; 50(4):503-7. PubMed ID: 106097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation among plasma osteocalcin, growth hormone, and somatomedin C in acromegaly.
    de la Piedra C; Larrañaga J; Castro N; Horcajada C; Rapado A; Herrera Pombo JL; Carbó E
    Calcif Tissue Int; 1988 Jul; 43(1):44-5. PubMed ID: 3145120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.